Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2
- 6 June 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 447 (7147), 959-965
- https://doi.org/10.1038/nature05844
Abstract
Adipocyte fatty-acid-binding protein, aP2 (FABP4) is expressed in adipocytes and macrophages, and integrates inflammatory and metabolic responses. Studies in aP2-deficient mice have shown that this lipid chaperone has a significant role in several aspects of metabolic syndrome, including type 2 diabetes and atherosclerosis. Here we demonstrate that an orally active small-molecule inhibitor of aP2 is an effective therapeutic agent against severe atherosclerosis and type 2 diabetes in mouse models. In macrophage and adipocyte cell lines with or without aP2, we also show the target specificity of this chemical intervention and its mechanisms of action on metabolic and inflammatory pathways. Our findings demonstrate that targeting aP2 with small-molecule inhibitors is possible and can lead to a new class of powerful therapeutic agents to prevent and treat metabolic diseases such as type 2 diabetes and atherosclerosis.Keywords
This publication has 29 references indexed in Scilit:
- Inflammation and metabolic disordersNature, 2006
- Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistanceProceedings of the National Academy of Sciences of the United States of America, 2006
- A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular diseaseProceedings of the National Academy of Sciences of the United States of America, 2006
- Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophagesBiochemical and Biophysical Research Communications, 2004
- A central role for JNK in obesity and insulin resistanceNature, 2002
- Macrophage Lipoprotein Lipase Promotes Foam Cell Formation and Atherosclerosis in Low Density Lipoprotein Receptor-deficient MicePublished by Elsevier BV ,2000
- Characterisation of receptor‐specific TNFα functions in adipocyte cell lines lacking type 1 and 2 TNF receptorsFEBS Letters, 2000
- PPARγ Activation Induces the Expression of the Adipocyte Fatty Acid Binding Protein Gene in Human MonocytesBiochemical and Biophysical Research Communications, 1999
- Selective immortalization of murine macrophages from fresh bone marrow by a raf/myc recombinant murine retrovirusNature, 1985
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959